Provided by Tiger Trade Technology Pte. Ltd.

InMed Pharmaceuticals Inc

1.46
-0.1200-7.59%
Post-market: 1.460.00000.00%17:48 EDT
Volume:71.61K
Turnover:107.41K
Market Cap:7.80M
PE:-0.58
High:1.62
Open:1.58
Low:1.45
Close:1.58
52wk High:2.50
52wk Low:0.5750
Shares:5.34M
Float Shares:1.93M
Volume Ratio:0.67
T/O Rate:3.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5324
EPS(LYR):-8.3630
ROE:-112.65%
ROA:-54.61%
PB:1.13
PE(LYR):-0.17

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 23, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 23, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 22, 2026

Major Issues Report

Form 8-K - Current report
Jul 20, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 10, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 10, 2026

Major Issues Report

Form 8-K - Current report
Jun 05, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 27, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2026

Major Issues Report

Form 8-K - Current report
Apr 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 27, 2026

Correspondence

Form CORRESP - Correspondence
Mar 23, 2026

Major Issues Report

Form 8-K - Current report